Functional Outcome
The primary outcome was functional outcome measured by the modified Rankin Scale (mRS). Participants also completed the Instrumental Activities of Daily Living (iADL) scale, which assesses the ability to execute complex tasks necessary for an independent life.
We considered a mRS >2 or a iADL <8 a poor functional outcome. Because there is no commonly used cut-off value for the iADL, we have chosen a cut-off value of <8 to indicate poor outcome because patients are dependent in daily life with a score <8.
Statistical Analysis
Chi-square test was used to analyze poor functional outcome (mRS) by the presence of incident stroke (IS or ICH) and by time of admission (before 1980, 1990-2000, and after 2000) . Odds ratios (95% confidence interval) are calculated by means of logistic regression for the risk of poor outcome in patients with IS only (because of small numbers with poor outcome in the other groups). Sex, age at event, duration of follow-up, National Institutes of Health Stroke Scale (NIHSS) at admission, incident strokes, and cardiovascular disease were considered confounders. We repeated this analysis without
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Results

Study Population
A total of 1005 patients fulfilled inclusion and exclusion criteria of the FUTURE study; of these patients, 46 were excluded because of a history of TIA or stroke, 82 were lost to follow-up, 153 refused to participate, and 2 did not provide any functional outcome measure resulting in 722 patients in the current analysis ( Figure) .
Functional Outcome As Assessed by the iADL
At follow-up, 17 survivors (10.8%) with TIA, 41 (14.6%) with IS, and 6 (18.2%) with ICH had a poor outcome on the iADL.
Contributing Factors
A total of 22 patients with TIA (10.6%), 64 patients with IS (14.3%), and 5 patients with ICH (7.5%) had ≥1 incident stroke during follow-up (P=0.167 for overall difference).
Patients with an incident stroke (n=91) more often had a poor functional outcome than patients without a recurrent stroke (mRS >2: 54.9% versus 28.7%; P<0.001 and iADL <8: 33.3% versus 11.5%; P<0.001).
In patients with the index event before 1990, between 1990 and 2000, and after 2000, the proportion with a poor functional outcome was 56.0%, 39.5%, and 18.3% (P<0.001 for overall difference). Between these groups there was no difference in outcome as assessed by the iADL. Stratification by stroke subtype showed a similar picture. There was no cohort effect with respect to age at index event or in the NIHSS at admission. Patients admitted before 1990 had more incident strokes than those admitted after 2000 (17.0% versus 10.1%; P=0.036).
Risk Factors
Risk factors for poor functional outcome (mRS >2) included the NIHSS and age at admission, incident stroke, sex, incident cardiovascular disease, and follow-up duration. Significant risk factors for an iADL <8 were NIHSS at admission and incident stroke. This did not change after exclusion of incident events ( Table 2 ).
Discussion
We showed that even after 10 years, ≈1 of 8 patients (12.9%) with an IS or ICH at young age was not able to function independently. In patients with TIA, this was 1 of 15 (6.5%) survivors. The strongest predictor of long-term functional outcome was the severity of the initial stroke. Also, there was a clear relationship between the occurrence of ≥1 incident strokes and poor long-term functional outcome, stressing the importance of optimal preventive strategies in this population.
Strengths of our study were the prospective and singlecenter design. Furthermore, our study has one of the longest follow-up durations and one of the largest cohorts. A limitation is the small number of patients with ICH, albeit the largest young ICH sample with long-term follow-up to date.
Furthermore, length of stay affects mRS at discharge and as a consequence a single group of patients with one and the same mRS at discharge might actually be composed out of several groups (with longer and shorter lengths of stay), each with their potential of recovery and thereby functional status at follow-up. 
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Recruitment of this cohort included 30 years during which major improvements in stroke care and secondary prevention took place. This was reflected by the on average better outcome in patients who had been admitted more recently and the higher proportion of incident stroke in the before 1990 cohort when compared with the cohorts thereafter although obviously those with a long follow-up have been exposed much longer, have become older, and are likely to have experienced more comorbidity that all may have accounted for a poorer functional outcome.
In previous studies, poor functional outcome in patients with IS ranged from 3% to 7% after mean follow-up durations between 4 and 12 years. [3] [4] [5] These studies showed a slightly better outcome than ours, possibly explained by our inclusion of older patients (≤50 instead of 45 years) or a longer follow-up in our study. Furthermore, in these previous studies, functional outcome was measured only by either the mRS or the Glasgow Outcome Scale, which are rather global scales for outcome. We intentionally used 2 different methods to determine functional outcome.
To conclude, prognosis after young ischemic and hemorrhagic stroke is rather poor; 1 of 8 young survivors with stroke is not able to live an independent life, even after ≈10 years after stroke.
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